Adicon Holdings (HKSE:09860) Change In Receivables : HK$0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Adicon Holdings Change In Receivables?

Adicon Holdings's change in receivables for the quarter that ended in Dec. 2023 was HK$0 Mil. It means Adicon Holdings's Accounts Receivable stayed the same from Jun. 2023 to Dec. 2023 .

Adicon Holdings's change in receivables for the fiscal year that ended in Dec. 2023 was HK$310 Mil. It means Adicon Holdings's Accounts Receivable declined by HK$310 Mil from Dec. 2022 to Dec. 2023 .

Adicon Holdings's Accounts Receivable for the quarter that ended in Dec. 2023 was HK$1,916 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Adicon Holdings's liquidation value for the six months ended in Dec. 2023 was HK$-342 Mil.

Adicon Holdings Change In Receivables Historical Data

The historical data trend for Adicon Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adicon Holdings Change In Receivables Chart

Adicon Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Change In Receivables

-338.05

-373.35

-725.56

309.85

Adicon Holdings Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial			-	-	-	-	-

Adicon Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

Adicon Holdings (HKSE:09860) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Adicon Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1915.899	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Adicon Holdings's accounts receivable are only considered to be worth 75% of book value:

Adicon Holdings's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1105.001	-	2980.491	+	0.75 * 1915.899	+	0.5 * 193.154
=	-342

Adicon Holdings Change In Receivables Related Terms

Thank you for viewing the detailed overview of Adicon Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Adicon Holdings (HKSE:09860) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Adicon Holdings Ltd (HKSE:09860) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

ADCNF:USA

Address

No. 208, Zhenzhong Road, West Lake, Zhejiang, Hangzhou, CHN

Website

https://www.adicon.com.cn

Adicon Holdings Ltd is one of the top three independent clinical laboratory or ICL, service providers in China. The company offers comprehensive and best-in-class testing services primarily to hospitals and health check centers through an integrated network of 33 self-operated laboratories across China. The high quality of its services is backed by its strong performance in terms of international accreditation and comprehensive testing menu. Its testing portfolio consists of over 4,000 medical diagnostic tests, including over 1,700 routine tests and over 2,300 esoteric tests. It has three major service platforms. Among them, the inspection service platform consists of clinical, pathology, reproductive genetic, genetic, and mass spectrometry laboratories.

Executives

Cap V General Partner, L.p.	2201 Interest of corporation controlled by you
Cap V, L.l.c.	2201 Interest of corporation controlled by you
Carlyle Asia Partners V, L.p.	2201 Interest of corporation controlled by you
Carlyle Holdings Ii Gp L.l.c.	2201 Interest of corporation controlled by you
Carlyle Holdings Ii L.l.c.	2201 Interest of corporation controlled by you
Cg Subsidiary Holdings L.l.c.	2201 Interest of corporation controlled by you
Pearl Group Limited	2101 Beneficial owner
Tc Group Cayman Investment Holdings L.p.	2201 Interest of corporation controlled by you
Tc Group Cayman Investment Holdings Sub L.p.	2201 Interest of corporation controlled by you
The Carlyle Group Inc.	2201 Interest of corporation controlled by you
Lin Feng
Mega Stream Limited
Trident Trust Company (hk) Limited	2301 Trustee
Ingenuity Capital Holdings Limited	2201 Interest of corporation controlled by you
Corelink Group Limited

Adicon Holdings (HKSE:09860) Headlines

No Headlines